About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Peptide Therapeutics Market Size, Share & Trends | 2033
Peptide Therapeutics Market

Peptide Therapeutics Market Size, Share & Trends Analysis Report By Application (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Anti-infection, Pain, Dermatology, CNS, Renal), By Type (Generic, Innovative), By Type of Manufacturers (In-house, Outsourced), By Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal), By Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI2277DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Peptide Therapeutics Market Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. U.S.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Canada
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. U.K.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. China
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. UAE
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Cancer
        1. By Value
      3. Metabolic
        1. By Value
      4. Cardiovascular Disorder
        1. By Value
      5. Respiratory
        1. By Value
      6. GIT
        1. By Value
      7. Anti-infection
        1. By Value
      8. Pain
        1. By Value
      9. Dermatology
        1. By Value
      10. CNS
        1. By Value
      11. Renal
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Generic
        1. By Value
      3. Innovative
        1. By Value
    4. By Type of Manufacturers
      1. Introduction
        1. Type of Manufacturers By Value
      2. In-house
        1. By Value
      3. Outsourced
        1. By Value
    5. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral Route
        1. By Value
      3. Oral Route
        1. By Value
      4. Pulmonary
        1. By Value
      5. Mucosal
        1. By Value
    6. By Synthesis Technology
      1. Introduction
        1. Synthesis Technology By Value
      2. Solid Phase Peptide Synthesis (SPPS)
        1. By Value
      3. Liquid Phase Peptide Synthesis (LPPS)
        1. By Value
      4. Hybrid Technology
        1. By Value
    7. Brazil
      1. By Application
        1. Introduction
          1. Application By Value
        2. Cancer
          1. By Value
        3. Metabolic
          1. By Value
        4. Cardiovascular Disorder
          1. By Value
        5. Respiratory
          1. By Value
        6. GIT
          1. By Value
        7. Anti-infection
          1. By Value
        8. Pain
          1. By Value
        9. Dermatology
          1. By Value
        10. CNS
          1. By Value
        11. Renal
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Generic
          1. By Value
        3. Innovative
          1. By Value
      3. By Type of Manufacturers
        1. Introduction
          1. Type of Manufacturers By Value
        2. In-house
          1. By Value
        3. Outsourced
          1. By Value
      4. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral Route
          1. By Value
        3. Oral Route
          1. By Value
        4. Pulmonary
          1. By Value
        5. Mucosal
          1. By Value
      5. By Synthesis Technology
        1. Introduction
          1. Synthesis Technology By Value
        2. Solid Phase Peptide Synthesis (SPPS)
          1. By Value
        3. Liquid Phase Peptide Synthesis (LPPS)
          1. By Value
        4. Hybrid Technology
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Peptide Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Eli Lilly and Company
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pfizer Inc.
    3. Amgen Inc.
    4. Takeda Pharmaceutical Company Limited
    5. Teva Pharmaceuticals Industries Ltd.
    6. Lonza Inc.
    7. Sanofi
    8. Bristol-Myers Squibb (BMS)
    9. AstraZeneca PLC
    10. GlaxoSmithKline plc (GSK)
    11. Novartis AG
    12. Novo Nordisk A/S
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market Overview The global autoimmune therapeutics market size was valued at USD 71.46 billion in 2024. It is estimated to reach USD 117.43 billion by 2032, growing at a CAGR of 5.69% during the forecast period (2024–2032). The global market i
Buy Now
Global Report
The global hepatitis B therapeutics market size was valued at USD 4.15 billion in 2023. It is estimated to reach USD 5.73 billion by 2032, growing at a CAGR of 3.65% during the forecast period (2024–2032). In the past few years, the rising glob
Buy Now
Global Report
Leukemia therapeutics are therapies used for treating leukemia at different levels. The earlier cancer is diagnosed and treated, the better the chance of its being cured. The game-changing technological advancements in the treatment of cancer are con
Buy Now
Global Report
The global microbiome therapeutics market size was worth USD 380 million in 2022 and is estimated to reach an expected value of USD 2,400 million by 2031, growing at a CAGR of 24.8% during the forecast period (2023 – 2031). Microbiome therapeu
Buy Now
Global Report
Pneumonia is a prevalent form of an acute respiratory infection that affects the alveoli of the lungs. Fungi, bacteria cause the disease, or viruses mediated infection. When an individual has pneumonia, the clinical manifestations can be as severe as
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.